We provide you with 20 years of free, institutional-grade data for MYOV stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of MYOV. Explore the full financial landscape of MYOV stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2023-01-26 | 1679082 | MYOV | 10-Q | Url |
| 2022-10-26 | 1679082 | MYOV | 10-Q | Url |
| 2022-07-27 | 1679082 | MYOV | 10-Q | Url |
| 2022-05-11 | 1679082 | MYOV | 10-K | Url |
| 2022-01-26 | 1679082 | MYOV | 10-Q | Url |
| 2021-10-26 | 1679082 | MYOV | 10-Q | Url |
| 2021-07-28 | 1679082 | MYOV | 10-Q | Url |
| 2021-05-11 | 1679082 | MYOV | 10-K | Url |
| 2021-02-11 | 1679082 | MYOV | 10-Q | Url |
| 2020-11-12 | 1679082 | MYOV | 10-Q | Url |
| 2020-08-11 | 1679082 | MYOV | 10-Q | Url |
| 2020-05-18 | 1679082 | MYOV | 10-K | Url |
| 2020-02-10 | 1679082 | MYOV | 10-Q | Url |
| 2019-11-12 | 1679082 | MYOV | 10-Q | Url |
| 2019-08-06 | 1679082 | MYOV | 10-Q | Url |
| 2019-05-24 | 1679082 | MYOV | 10-K | Url |
| 2019-02-07 | 1679082 | MYOV | 10-Q | Url |
| 2018-11-08 | 1679082 | MYOV | 10-Q | Url |
| 2018-08-07 | 1679082 | MYOV | 10-Q | Url |
| 2018-06-07 | 1679082 | MYOV | 10-K | Url |
| 2018-02-13 | 1679082 | MYOV | 10-Q | Url |
| 2017-11-13 | 1679082 | MYOV | 10-Q | Url |
| 2017-08-10 | 1679082 | MYOV | 10-Q | Url |
| 2017-06-14 | 1679082 | MYOV | 10-K | Url |
| 2017-02-13 | 1679082 | MYOV | 10-Q | Url |
| 2016-12-09 | 1679082 | MYOV | 10-Q | Url |
| 2016-09-30 | 1679082 | MYOV | S-1 | Url |
Myovant Sciences Ltd(NYSE:MYOV) 
Myovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for women's health and endocrine diseases. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antago...
Website: http://myovant.com
Founded: 2016
Full Time Employees: 407 (May 2021)
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about MYOV stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.